GIA
ABBV icon

GHP Investment Advisors’s AbbVie ABBV Stock Holding History

GHP Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
5,799
+208
+4% +$44.8K 0.05% 264
2026
Q1 		$1.22M Sell
5,591
-260
-4% -$57.7K 0.05% 263
2025
Q4 		$1.34M Buy
5,851
+92
+2% +$21K 0.06% 256
2025
Q3 		$1.33M Sell
5,759
-65
-1% -$13.2K 0.06% 254
2025
Q2 		$1.08M Sell
5,824
-212
-4% -$39.4K 0.05% 263
2025
Q1 		$1.26M Buy
6,036
+79
+1% +$15.4K 0.06% 251
2024
Q4 		$1.06M Sell
5,957
-158
-3% -$29K 0.05% 265
2024
Q3 		$1.21M Buy
6,115
+314
+5% +$58.6K 0.06% 256
2024
Q2 		$995K Buy
5,801
+90
+2% +$14.9K 0.05% 264
2024
Q1 		$1.04M Sell
5,711
-50
-0.9% -$8.62K 0.05% 266
2023
Q4 		$893K Sell
5,761
-526
-8% -$76.7K 0.05% 270
2023
Q3 		$930K Buy
6,287
+418
+7% +$61.4K 0.06% 264
2023
Q2 		$893K Buy
5,869
+226
+4% +$33.1K 0.05% 268
2023
Q1 		$899K Sell
5,643
-248
-4% -$37.9K 0.06% 263
2022
Q4 		$952K Buy
5,891
+50
+0.9% +$7.67K 0.06% 256
2022
Q3 		$784K Sell
5,841
-1
-0% -$143 0.06% 253
2022
Q2 		$895K Sell
5,842
-358
-6% -$54.7K 0.07% 247
2022
Q1 		$1M Sell
6,200
-53
-0.8% -$7.7K 0.07% 242
2021
Q4 		$847K Sell
6,253
-1,087
-15% -$128K 0.06% 225
2021
Q3 		$792K Sell
7,340
-270
-4% -$30.9K 0.06% 214
2021
Q2 		$857K Buy
7,610
+1,635
+27% +$184K 0.07% 201
2021
Q1 		$647K Buy
5,975
+210
+4% +$22.5K 0.06% 215
2020
Q4 		$618K Sell
5,765
-9
-0.2% -$865 0.06% 207
2020
Q3 		$506K Sell
5,774
-64
-1% -$6.03K 0.06% 215
2020
Q2 		$573K Sell
5,838
-2,365
-29% -$208K 0.07% 210
2020
Q1 		$625K Buy
8,203
+2,292
+39% +$195K 0.09% 201
2019
Q4 		$523K Buy
5,911
+158
+3% +$13.1K 0.06% 230
2019
Q3 		$436K Sell
5,753
-96
-2% -$6.58K 0.05% 241
2019
Q2 		$425K Buy
5,849
+9
+0.2% +$707 0.05% 242
2019
Q1 		$471K Buy
5,840
+115
+2% +$9.41K 0.06% 228
2018
Q4 		$528K Buy
5,725
+7
+0.1% +$616 0.08% 214
2018
Q3 		$541K Sell
5,718
-652
-10% -$61.8K 0.07% 220
2018
Q2 		$590K Buy
6,370
+400
+7% +$39.1K 0.08% 210
2018
Q1 		$565K Hold
5,970
– – 0.08% 221
2017
Q4 		$577K Buy
5,970
+455
+8% +$42.9K 0.08% 219
2017
Q3 		$490K Hold
5,515
– – 0.07% 229
2017
Q2 		$400K Hold
5,515
– – 0.06% 244
2017
Q1 		$359K Hold
5,515
– – 0.06% 248
2016
Q4 		$345K Buy
5,515
+76
+1% +$4.64K 0.06% 246
2016
Q3 		$343K Hold
5,439
– – 0.07% 238
2016
Q2 		$337K Sell
5,439
-33
-0.6% -$2.01K 0.07% 240
2016
Q1 		$313K Buy
5,472
+33
+0.6% +$1.84K 0.07% 239
2015
Q4 		$322K Hold
5,439
– – 0.08% 233
2015
Q3 		$296K Buy
5,439
+200
+4% +$13K 0.08% 227
2015
Q2 		$357K Sell
5,239
-15
-0.3% -$979 0.09% 218
2015
Q1 		$308K Hold
5,254
– – 0.08% 218
2014
Q4 		$344K Buy
5,254
+15
+0.3% +$946 0.09% 202
2014
Q3 		$303K Hold
5,239
– – 0.09% 212
2014
Q2 		$296K Hold
5,239
– – 0.09% 211
2014
Q1 		$269K Hold
5,239
– – 0.09% 217
2013
Q4 		$277K Sell
5,239
-412
-7% -$20.2K 0.09% 213
2013
Q3 		$253K Sell
5,651
-332
-6% -$14.7K 0.09% 222
2013
Q2 		$247K Buy
+5,983
New +$262K 0.1% 214

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GHP Investment Advisors's ABBV Position: Q2 2026 in Review

GHP Investment Advisors increased its AbbVie (ABBV) stake by 3.7% in Q2 2026, buying an estimated $44.8K and bringing the position to 5,799 shares worth $1.46M. The position accounts for 0.05% of the portfolio, ranked #264.

GHP Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • GHP Investment Advisors held 5,799 shares of AbbVie worth $1.46M as of Q2 2026.
  • GHP Investment Advisors bought 208 AbbVie shares in Q2 2026, an estimated $44.8K.
  • AbbVie made up 0.05% of GHP Investment Advisors's portfolio in Q2 2026, its #264 holding.
  • GHP Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.